Dr. Gary Landreth and colleagues at Case Western Reserve published a paper online in Science Express yesterday that received much attention because of the rather stunning results it reports in stopping and even reversing “a broad range of Abeta-induced deficits."
Exercise and stimulation of the brain may help ward off Alzheimer's disease, according to Dr. Tanzi and Dr. Gandy, both Cure Alzheimer's Fund Research Consortium members who were recently quoted in an article in the AARP Bulletin.
Upon the announcement that the Obama administration will put $156 million toward Alzheimer’s research within the next two years, ABC news covered the story and quoted Cure Alzheimer’s President and CEO Tim Armour:
“Alzheimer’s threatens to bankrupt our health care system, affect the quality of care provided to patients and mature into one of the worst health care crises our nation has ever seen,” Armour said.
Findings from Cure Alzheimer’s Fund Help Drive the Alzheimer’s Initiative
“Alzheimer’s takes a devastating toll on millions of Americans,” said Kathleen Sebelius, secretary of Health and Human Services. “It’s a very important health issue. The time for bold action is right now.”
On Saturday morning, April 28, co-founders Carolyn Mastrangelo and Barbara Geiger will hold the third annual Running 4 Answers fundraiser on the tree-lined streets of historic Roseland and Essex Fells, N.J. This four-mile race/two-mile fun run/walk brings families together to honor loved ones whom they have lost to Alzheimer’s and helps raise money toward finding a cure. The event is sanctioned by USATrack & Field–New Jersey.
Dr. Rudolph Tanzi, chairman of the Cure Alzheimer’s Fund Research Consortium, is now featured on the Discovery Channel-based website Curiosity.com. Tanzi provides answers to numerous questions posed by Curiosity with the intention of informing the public about Alzheimer’s disease and the Alzheimer’s Genome Project™.
To see some of the answers to today’s most pressing questions about Alzheimer’s, click here.
For the last 27 years, Abeta, a fatty protein that is created in the brain, has been identified as the leading cause of Alzheimer’s disease. As a result, the majority of efforts aimed at developing a cure have targeted Abeta as the enemy. But recent studies have indicated that simply wiping out Abeta in the brain is not the solution.